Literature DB >> 8268906

Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.

H Telenius1, H P Kremer, J Theilmann, S E Andrew, E Almqvist, M Anvret, C Greenberg, J Greenberg, G Lucotte, F Squitieri.   

Abstract

Juvenile Huntington disease (HD), characterised by onset of symptoms before the age of 20 with rigidity and intellectual decline, is associated with a predominance of affected fathers. In order to investigate the molecular basis for the observed parental effect, we have analysed the CAG trinucleotide repeat within the HD gene in 42 juvenile onset cases from 34 families. A highly significant correlation was found between the repeat length and age of onset (r = -0.86, p < 10(-7) and it was determined that the sex of transmitting parent was the major influence on CAG expansion leading to earlier onset. Neither the size of the parental upper allele, the age of parent at conception of juvenile onset child, nor the grandparental sex conferred a significant effect upon expansion. Affected sib pair analysis of CAG repeat length, however, revealed a high correlation (r = 0.91, p < 10(-7). Furthermore, analysis of nuclear and extended families showed a familial predisposition to juvenile onset disease. This study demonstrates that the sex of transmitting parent is the major influence on trinucleotide expansion and clinical features in juvenile Huntington disease.

Entities:  

Mesh:

Year:  1993        PMID: 8268906     DOI: 10.1093/hmg/2.10.1535

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

Review 1.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Authors:  Damian M Cummings; Yasaman Alaghband; Miriam A Hickey; Prasad R Joshi; S Candice Hong; Chunni Zhu; Timothy K Ando; Véronique M André; Carlos Cepeda; Joseph B Watson; Michael S Levine
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

3.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

Review 4.  Huntington disease--another chapter rewritten.

Authors:  M A Nance
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

5.  Update on genetics of Huntington's disease: availability of direct and accurate predictive test.

Authors:  F Squitieri; G Campanella; M R Hayden
Journal:  Ital J Neurol Sci       Date:  1996-06

6.  Familial transmission of the FMR1 CGG repeat.

Authors:  S L Nolin; F A Lewis; L L Ye; G E Houck; A E Glicksman; P Limprasert; S Y Li; N Zhong; A E Ashley; E Feingold; S L Sherman; W T Brown
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Avoiding errors in the diagnosis of (CAG)n expansion in the huntingtin gene.

Authors:  C Holzmann; A M Saecker; J T Epplen; O Riess
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

8.  Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset.

Authors:  L P Ranum; M Y Chung; S Banfi; A Bryer; L J Schut; R Ramesar; L A Duvick; A McCall; S H Subramony; L Goldfarb
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

9.  Early onset Huntington disease: a neuronal degeneration syndrome.

Authors:  Sara Seneca; Domique Fagnart; Kathelijn Keymolen; Willy Lissens; Daniele Hasaerts; Sara Debulpaep; Brigitte Desprechins; Inge Liebaers; Linda De Meirleir
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

10.  "Grasping the grey": patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease.

Authors:  A Semaka; L G Balneaves; M R Hayden
Journal:  J Genet Couns       Date:  2012-08-18       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.